최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Biomaterials, v.211, 2019년, pp.25 - 47
Rathore, Bhowmira (Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, College of Physics and Optoelectronic Engineering, Shenzhen University) , Sunwoo, Kyoung (Department of Chemistry, Korea University) , Jangili, Paramesh (Department of Chemistry, Korea University) , Kim, Jiseon (Department of Chemistry, Korea University) , Kim, Ji Hyeon (Department of Chemistry, Korea University) , Huang, Meina (Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, College of Physics and Optoelectronic Engineering, Shenzhen University) , Xiong, Jia (Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, College of Physics and Optoelectronic Engineering, Shenzhen University) , Sharma, Amit (Department of Chemistry, Korea University Republic of Korea<) , Yang, Zhigang , Qu, Junle , Kim, Jong Seung
Abstract Lysosomes, an important organelle of eukaryotic cells, are covered with the cell membrane and contain an array of degradative enzymes. The disrupt in lysosomal functions may lead to the development of severe diseases. In nanotechnology, nanomaterials working mechanism and its biomedical ou...
Chem. Rev. Lim 115 327 2015 10.1021/cr300213b Nanomaterials for theranostics: recent advances and future challenges
J. Am. Chem. Soc. Wu 136 3579 2014 10.1021/ja412380j In Vivo and in Situ tracking cancer chemotherapy by highly photostable NIR fluorescent theranostic prodrug
Biomaterials Wu 120 1 2017 10.1016/j.biomaterials.2016.11.011 Real-time near-infrared bioimaging of a receptor-targeted cytotoxic dendritic theranostic agent
Chem. Soc. Rev. Lee 47 1 28 2018 10.1039/C7CS00557A Fluorogenic reaction-based prodrug conjugates as targeted cancer theranostics
For. Rep. Wilczewska 64 1020 2012 Nanoparticles as drug delivery systems, Pharmacol
Chem. Soc. Rev. Yang 42 530 2013 10.1039/C2CS35342C Nano-graphene in biomedicine: theranostic applications
Expert Opin. Biol. Ther. Rettig 7 799 2007 10.1517/14712598.7.6.799 Non-viral gene delivery: from the needle to the nucleus
Eur. J. Pharm. Biopharm. Breunig 68 112 2008 10.1016/j.ejpb.2007.06.010 Polymers and nanoparticles: intelligent tools for intracellular targeting?
Curr. Drug Metabol. Frohlich 14 976 2013 10.2174/1389200211314090004 Cellular targets and mechanisms in the cytotoxic action of non-biodegradable engineered nanoparticles
Adv. Drug Deliv. Rev. Anozie 122 65 2017 10.1016/j.addr.2017.01.001 Molecular links among non-biodegradable nanoparticles, reactive oxygen species, and autophagy
J. Control. Release Muro 164 125 2012 10.1016/j.jconrel.2012.05.052 Challenges in design and characterization of ligand-targeted drug delivery systems
Manthe 261 2014 Lysosomes and Nanotherapeutics: Diseases, Treatments, and Side Effects. Handbook of Nanobiomedical Research: Fundamentals, Applications and Recent Developments: Volume 2. Applications in Therapy
Org. Biomol. Chem. Hong 16 8025 2018 10.1039/C8OB01957F Synthesis and properties of a lysosome-targeting fluorescent ionophore based on coumarins and squaramides
Sen. Act. B Shen 256 261 2018 10.1016/j.snb.2017.10.103 A near-infrared lysosomal pH probe based on rhodamine derivative
Sen. Act. B Yu 252 313 2017 10.1016/j.snb.2017.05.164 Near-infrared lysosome pH tracker and naked-eye colorimetric nucleic acids sensor based on ruthenium complexes [Ru(bim)2(dppz)]2+ and [Ru(bim)2(pip)]2+
Nat. Biotechnol. Blanco 33 941 2015 10.1038/nbt.3330 Principles of nanoparticle design for overcoming biological barriers to drug delivery
J. Colloid Interf. Sci. Chen 484 298 2016 10.1016/j.jcis.2016.09.009 Design and fabrication of fluorescence resonance energy transfer-mediated fluorescent polymer nanoparticles for ratiometric sensing of lysosomal pH
Angew. Chem. Int. Ed. Chen 57 12519 2018 10.1002/anie.201807373 Supramolecular assemblies with near-infrared emission mediated in two stages by cucurbituril and amphiphilic calixarene for lysosome-targeted cell imaging
Chem. Commun. Pramanik 53 12672 2017 10.1039/C7CC08185E Imaging cellular trafficking processes in real time using lysosome targeted up-conversion nanoparticles
ACS Appl. Bio Mater. Yuan 1 511 2018 10.1021/acsabm.8b00238 High-Yield method to fabricate and functionalize DNA nanoparticles from the products of rolling circle amplification
RSC Adv. Zeng 5 57725 2015 10.1039/C5RA07535A Fast and facile preparation of PEGylated graphene from graphene oxide by lysosome targeting delivery of photosensitizer to efficiently enhance photodynamic therapy
Chem. Commun. Xiang 52 148 2016 10.1039/C5CC07006F Tumor cell specific and lysosome-targeted delivery of nitric oxide for enhanced photodynamic therapy triggered by 808 nm near-infrared light
Chem. Soc. Rev. Sharma 48 771 2019 10.1039/C8CS00304A Hypoxia-targeted drug delivery
J. Mater. Chem. B Gangopadhyay 4 1862 2016 10.1039/C5TB02563J Fluorene-morpholine-based organic nanoparticles: lysosome-targeted pH-triggered two-photon photodynamic therapy with fluorescence switch on-off
ACS Appl. Mater. Inter. Hu 8 12039 2016 10.1021/acsami.6b02721 Engineering Lysosome-Targeting BODIPY nanoparticles for photoacoustic imaging and photodynamic therapy under Near-Infrared light
Oncogene Boya 27 6434 2008 10.1038/onc.2008.310 Lysosomal membrane permeabilization in cell death
Autophagy Bourdenx 12 472 2016 10.1080/15548627.2015.1136769 Nanoparticles restore lysosomal acidification defects: implications for Parkinson and other lysosomal-related diseases
Biochem. Soc. Trans. Serrano-Puebla 46 207 2018 10.1042/BST20170130 Lysosomal membrane permeabilization as a cell death mechanism in cancer cells
Traffic Wang 19 918 2018 10.1111/tra.12613 Lysosomal membrane permeabilization and cell death
Oncogene Boya 27 6434 2008 10.1038/onc.2008.310 Lysosomal membrane permeabilization in cell death
Mitochondrion Repnik 19 49 2014 10.1016/j.mito.2014.06.006 Lysosomal membrane permeabilization in cell death: concepts and challenges
Oncogene Jaattela 23 2746 2004 10.1038/sj.onc.1207513 Multiple cell death pathways as regulators of tumour initiation and progression
Chem. Commun. Gao 50 8117 2014 10.1039/c4cc03793f Targeting lysosomal membrane permeabilization to induce and image apoptosis in cancer cells by multifunctional Au-ZnO hybrid nanoparticles
Chem. Commun. Xue 53 842 2017 10.1039/C6CC08296C Tumor-targeted supramolecular nanoparticles self-assembled from a ruthenium-β-cyclodextrin complex and an adamantane-functionalized peptide
Chem. Soc. Rev. Zeng 46 5771 2017 10.1039/C7CS00195A The development of anticancer ruthenium(II) complexes: from single molecule compounds to nanomaterials
ACS Nano Sanchez 8 1350 2014 10.1021/nn404954s Targeting a G-protein-coupled receptor overexpressed in endocrine tumors by magnetic nanoparticles to induce cell death
J. Control. Release Clerc 270 120 2018 10.1016/j.jconrel.2017.11.050 Targeted magnetic intra-lysosomal hyperthermia produces lysosomal reactive oxygen species and causes caspase-1 dependent cell death
Nanoscale Cheng 9 17063 2017 10.1039/C7NR05450E A drug-self-gated and tumor microenvironment-responsive mesoporous silica vehicle:“four-in-one” versatile nanomedicine for targeted multidrug-resistant cancer therapy
Biomacromolecules Aluri 19 2166 2018 10.1021/acs.biomac.8b00334 Multistimuli-responsive amphiphilic poly (ester-urethane) nanoassemblies based on L-tyrosine for intracellular drug delivery to cancer cells
Chem Sharma 4 2370 2018 10.1016/j.chempr.2018.08.002 Overcoming drug resistance by targeting cancer bioenergetics with an activatable prodrug
RSC Adv. Wu 6 69083 2016 10.1039/C6RA04219H Biotinylated carboxymethyl chitosan/CaCO 3 hybrid nanoparticles for targeted drug delivery to overcome tumor drug resistance
Front. Physiol. Leanza 4 227 2013 10.3389/fphys.2013.00227 Intracellular ion channels and cancer
Chem. Commun. Ju 52 12598 2016 10.1039/C6CC06467A Embedding magnetic nanoparticles into coordination polymers to mimic zinc ion transporters for targeted tumor therapy
Mater. Sci. Eng. C Huang 70 763 2017 10.1016/j.msec.2016.09.052 Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics
ACS Nano Lee 9 9859 2015 10.1021/acsnano.5b05138 Enhanced human epidermal growth factor receptor 2 degradation in breast cancer cells by lysosome-targeting gold nanoconstructs
Chem. Commun. Li 54 3520 2018 10.1039/C8CC00440D pH-Responsive spherical nucleic acid for intracellular lysosome imaging and an effective drug delivery system
Nat. Rev. Mol. Cell Biol. Futerman 5 554 2004 10.1038/nrm1423 The cell biology of lysosomal storage disorders
J. Cell Biol. Platt 199 723 2012 10.1083/jcb.201208152 Lysosomal storage disorders: the cellular impact of lysosomal dysfunction
Drug. Deliv. Transl. Re. Muro 2 169 2012 10.1007/s13346-012-0072-4 Strategies for delivery of therapeutics into the central nervous system for treatment of lysosomal storage disorders
Int. J. Mol. Med. Parenti 31 11 2013 10.3892/ijmm.2012.1187 New strategies for the treatment of lysosomal storage diseases (review)
Mol. Genet. Metabol. Brunetti-Pierri 94 391 2008 10.1016/j.ymgme.2008.04.012 GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects
ACS Omega Gupta 2 9002 2017 10.1021/acsomega.7b01230 Intracellular delivery of β-Galactosidase enzyme using Arginase-Responsive dextran Sulfate/Poly-l-arginine capsule for lysosomal storage disorder
Eur. J. Pharm. Biopharm. Donida 133 96 2018 10.1016/j.ejpb.2018.10.005 Monoolein-based nanoparticles for drug delivery to the central nervous system: a platform for lysosomal storage disorder treatment
Cell Zamore 101 25 2000 10.1016/S0092-8674(00)80620-0 RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals
J. Mater. Chem. B Li 4 6620 2016 10.1039/C6TB01462C Nanoparticle delivery systems for siRNA-based therapeutics
J. Nanomater. Guo 2011 11 2011 10.1155/2011/742895 Nanoparticles escaping RES and endosome: challenges for siRNA delivery for cancer therapy
J. Control. Release Chen 259 105 2017 10.1016/j.jconrel.2017.01.042 Tumor-targeted pH/redox dual-sensitive unimolecular nanoparticles for efficient siRNA delivery
Nanobiomedicine Berger 4 1 2017 10.1177/1849543517746259 Cytotoxicity assessment, inflammatory properties, and cellular uptake of Neutraplex lipid-based nanoparticles in THP-1 monocyte-derived macrophages
RSC Adv. Cerda 5 58345 2015 10.1039/C5RA06562C Enhancement of nucleic acid delivery to hard-to-transfect human colorectal cancer cells by magnetofection at laminin coated substrates and promotion of the endosomal/lysosomal escape
J. Control. Release Joris 269 266 2018 10.1016/j.jconrel.2017.11.019 Repurposing cationic amphiphilic drugs as adjuvants to induce lysosomal siRNA escape in nanogel transfected cells
Angew. Chem. Int. Ed. Yuan 54 11419 2015 10.1002/anie.201503640 A photoactivatable AIE polymer for light-controlled gene delivery: concurrent endo/lysosomal escape and DNA unpacking
Nanoscale Chen 7 14080 2015 10.1039/C5NR03527A Overcoming acquired drug resistance in colorectal cancer cells by targeted delivery of 5-FU with EGF grafted hollow mesoporous silica nanoparticles
Theranostics Zhou 7 764 2017 10.7150/thno.15757 Size-tunable Gd2O3@albumin nanoparticles conjugating chlorin e6 for magnetic resonance imaging-guided photo-induced therapy
Nanoscale Li 9 314 2017 10.1039/C6NR07004C A pH-responsive sequential-disassembly nanohybrid for mitochondrial targeting
Adv. Funct. Mater. Wang 28 1706124 2018 10.1002/adfm.201706124 Multifunctional shell-core nanoparticles for treatment of multidrug resistance hepatocellular carcinoma
Int. J. Nanomed. Liu 12 8085 2017 10.2147/IJN.S149070 Zinc oxide nanoparticles induce toxic responses in human neuroblastoma SHSY5Y cells in a size-dependent manner
ACS Nano Mirshafiee 12 3836 2018 10.1021/acsnano.8b01086 Toxicological profiling of metal oxide nanoparticles in liver context reveals pyroptosis in Kupffer cells and macrophages versus apoptosis in hepatocytes
RSC Adv. Ge 6 21725 2016 10.1039/C6RA01625A Europium-doped NaYF4 nanoparticles cause the necrosis of primary mouse bone marrow stromal cells through lysosome damage
Genes Dev. Mizushima 21 2861 2007 10.1101/gad.1599207 Autophagy: process and function
J. Pathol. Glick 221 3 2010 10.1002/path.2697 Autophagy: cellular and molecular mechanisms
FEBS J. Mrschtik 282 1858 2015 10.1111/febs.13253 Lysosomal proteins in cell death and autophagy
J. Cell Sci. Nakamura 130 1209 2017 10.1242/jcs.196352 New insights into autophagosome-lysosome fusion
Toxicol. Lett. Wan 221 118 2013 10.1016/j.toxlet.2013.06.208 Single-walled carbon nanotubes and graphene oxides induce autophagosome accumulation and lysosome impairment in primarily cultured murine peritoneal macrophages
Autophagy Cohignac 14 1323 2018 10.1080/15548627.2018.1474993 Carbon nanotubes, but not spherical nanoparticles, block autophagy by a shape-related targeting of lysosomes in murine macrophages
Nano Lett. Xue 14 5110 2014 10.1021/nl501839q Single-walled carbon nanotubes alleviate autophagic/lysosomal defects in primary glia from a mouse model of Alzheimer's disease
J. Mater. Chem. B Zhou 6 8127 2018 10.1039/C8TB02390E Gold nanoparticles impair autophagy flux through shape-dependent endocytosis and lysosomal dysfunction
J. Hazard Mater. Yu 270 176 2014 10.1016/j.jhazmat.2014.01.028 Silica nanoparticles induce autophagy and autophagic cell death in HepG2 cells triggered by reactive oxygen species
Int. J. Nanomed. Duan 9 5131 2014 10.2147/IJN.S71074 Silica nanoparticles induce autophagy and endothelial dysfunction via the PI3K/Akt/mTOR signaling pathway
Int. J. Nanomed. Wang 12 809 2017 10.2147/IJN.S123596 Silica nanoparticles induce autophagy dysfunction via lysosomal impairment and inhibition of autophagosome degradation in hepatocytes
RSC Adv. Zhang 8 4130 2018 10.1039/C7RA11400A Palladium nanoparticles induces autophagy and autophagic flux blockade in HeLa cells
J. Cell Biol. Trudeau 214 25 2016 10.1083/jcb.201511042 Lysosome acidification by photoactivated nanoparticles restores autophagy under lipotoxicity
Nano Lett. Ding 17 6790 2017 10.1021/acs.nanolett.7b03021 Intracellular fate of nanoparticles with polydopamine surface engineering and a novel strategy for exocytosis-inhibiting, lysosome impairment-based cancer therapy
ACS Nano Zhu 12 2922 2018 10.1021/acsnano.8b00516 Intracellular mechanistic understanding of 2D MoS2 nanosheets for anti-exocytosis-enhanced synergistic cancer therapy
Adv. Mater. Tao 29 1603276 2017 10.1002/adma.201603276 Black phosphorus nanosheets as a robust delivery platform for cancer theranostics
Adv. Mater. Tao 30 1802061 2018 10.1002/adma.201802061 Twodimensional antimonenebased photonic nanomedicine for cancer theranostics
Drug Deliv. Li 24 45 2017 10.1080/10717544.2017.1391889 Transporting carriers for intracellular targeting delivery via non-endocytic uptake pathways
J. Am. Chem. Soc. Herce 136 17459 2014 10.1021/ja507790z Fundamental molecular mechanism for the cellular uptake of guanidinium-rich molecules
Accounts Chem. Res. Walrant 50 2968 2017 10.1021/acs.accounts.7b00455 Membrane crossing and membranotropic activity of cell-penetrating peptides: dangerous liaisons?
Bioconjug. Chem. Wei 20 1752 2009 10.1021/bc8003777 Surface coating directed cellular delivery of TAT-functionalized quantum dots
J. Med. Chem. Montet 49 6087 2006 10.1021/jm060515m Multivalent effects of RGD peptides obtained by nanoparticle display
J. Am. Chem. Soc. Rothbard 126 9506 2004 10.1021/ja0482536 Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells
ASC Nano Lin 7 10799 2013 10.1021/nn4040553 Cell membranes open “Doors” for cationic nanoparticles/biomolecules: insights into uptake kinetics
Sci. Rep-UK Bossi 6 22254 2016 10.1038/srep22254 Cobalt oxide nanoparticles can enter inside the cells by crossing plasma membranes
J. Am. Chem. Sci. Derivery 139 10172 2017 10.1021/jacs.7b02952 Efficient delivery of quantum dots into the cytosol of cells using cell-penetrating poly(disulfide)s
ACS Appl. Bio Mater. Ghosh 2 339 2019 10.1021/acsabm.8b00617 Arginine-Terminated, chemically designed nanoparticle for direct cell translocation
Angew. Chem. Jiang 127 516 2015 10.1002/ange.201409161 Direct cytosolic delivery of siRNA using nanoparticle-stabilized nanocapsules
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.